Insider Moves: ADAR1 Increases NextCure Stake as Directors and Executives Shuffle Holdings
Insider filings disclosed on Tuesday covering transactions from late July and early August 2026 show a mix of concentrated purchases and large disposals across sectors including biotechnology, retail, insurance, medical devices, automotive and commercial trucks. ADAR1 Capital Management, LLC made a sizable buy in NextCure totaling $1.62 million whi…